Schwabl, Philipp http://orcid.org/0000-0002-7183-8076
Brusilovskaya, Ksenia
Supper, Paul
Bauer, David
Königshofer, Philipp http://orcid.org/0000-0003-1279-1148
Riedl, Florian
Hayden, Hubert
Fuchs, Claudia Daniela
Stift, Judith
Oberhuber, Georg
Aschauer, Stefan
Bonderman, Diana
Gnad, Thorsten
Pfeifer, Alexander
Uschner, Frank Erhard
Trebicka, Jonel
Rohr-Udilova, Nataliya
Podesser, Bruno Karl
Peck-Radosavljevic, Markus
Trauner, Michael
Reiberger, Thomas http://orcid.org/0000-0002-4590-3583
Article History
Received: 9 January 2018
Accepted: 5 June 2018
First Online: 19 June 2018
Competing Interests
: P.Sc. has received speaker fees from Roche and Boehringer Ingelheim, and travel support from Roche, Boehringer Ingelheim and Gilead. D.Bo. has received fees and research grants from Bayer, AOP Orphan, United Therapeutics, Actelion, Pfizer and Novartis. M.P.R. has received advisory board fees from Abbott, Bayer, BMS, Boehringer-Ingelheim, Gilead, MSD, Roche; has received grants from Abbott, Bayer, Gilead, MSD and Roche. M.T. has received advisory board fees from Falk, Phenex, Albireo, Novartis, Gilead, MSD, Intercept and BMS; has received speaker fees from Falk, Gilead, Roche and MSD; has received grants from Intercept, Albireo, Falk, MSD and Takeda. T.R. received travel support from Roche, MSD, Boehringer Ingelheim and Gilead; received honoraria for lectures from Roche, Boehringer-Ingelheim and MSD, and received research support from Boehringer-Ingelheim and Abbvie. K.B., P.Su., D.Ba., P.K., F.R., H.H., C.D.F., J.S., G.O., S.A., T.G., A.P., F.E.U., J.T., N.R.U. and B.K.P. have no conflicts of interest.